Keep up to date on the latest medical news at MDLinx - FREE!

  • Stay current on the latest medical literature, research and clinical news
  • MD jobs and physician job search at our new medical job Career Center
  • Receive invitations to paid market research
  • Search Clinical Trials and Medical Conferences

register to view free medical at articles at MDLinx

Follow Us

Posts by category

MDLinx Blog - Medical News and more.

Current Articles | RSS Feed RSS Feed

What are Rheumatologists Really Doing Online


What are Rheumatologists Really Doing Online? We know, and we want to tell you.

Did you know that M3 MDLinx is the leading digital provider of clinical news and information to over 85% of all US Rheumatologists?.

Did you know that M3 MDLinx is the leading digital provider of clinical news and information to over 85% of all US Rheumatologists?

Did you know that majority of Rheumatologists actually spend more time online engaged in activities that support care for their patients than on seeking information about new medical advances in their field? Did you think the two were the same? According to Rheumatologists, they aren't.

spending their time on and offline, and what matters most to them. We surveyed over 100 Rheumatologists in the United States, who see at least 200 patients per month, and discovered not just how doctors are communicating with pharma companies, their peers and their patients, but much more. We asked them:

  • How do you want pharma and biotech companies to communicate with you in comparison to how they communicate with you today?
  • Do your pharma and biotech reps provide you with the tools and knowledge you need to best do your job? What can they do better?
  • How often and through what outlets do you interact online for research, news, social, and informational purposes?
  • How often, in what forms and for what reason do you use technology most? How can pharma brands better utilize technology?
  • If you want a basic study with stock answers that vary slightly from year to year, you shouldn't call us. But if you want the inside scoop on what Rheumatologists really want and need, and insight on how they get information and how they share it, you should contact us today.

To learn more about the details of The CompleteRheumatologist Study or purchase the report, contact MDLinx to learn more.



Serum B-cell activating factor assessment in a population of Egyptian patients with systemic sclerosis

International Journal of Rheumatic Diseases, 12/19/2012

Abdo MS et al. – To assess serum B–cell activating factor (BAFF) levels in patients with systemic sclerosis and to correlate this with disease features and disease severity. Serum BAFF levels were significantly elevated in patients with systemic sclerosis irrespective of disease subtype, disease duration or age of patients. This elevation in serum BAFF significantly related to gastrointestinal track involvement and methotrexate therapy.


    • This is a case-control study in which patients with the established diagnosis of SSc were recruited.
    • The diagnosis of SSc was established according to the American Rheumatology Association 1980 criteria for the classification of scleroderma.
    • Patients' assessment included evaluation of skin involvement using the Modified Rodnan score and disease severity using the Medsger score.
    • Twenty-five healthy matching controls were included.
    • The sandwich enzyme-linked immunosorbent assay technique was used for direct assessment of serum BAFF in patients and controls


    • The study included 60 patients (54 female and 6 male), with a mean age of 38.18±12.06 years, with mean disease duration of 7.85±4.075 years.
    • Serum BAFF in patients ranged 98.2-5015 pg/mL with mean BAFF 1100±835.4 pg/mL.
    • In controls serum BAFF levels ranged 188.5-2314 pg/mL with mean BAFF 546.1±471.1 pg/mL, showing a statistically significant elevation of serum BAFF levels in SSc patients (P=0.0001) with insignificant correlation to skin disease or total Medsgar Score of the study population (P>0.05).
    • Serum BAFF levels showed significant correlation with episodes of pseudo-obstruction and methotrexate (MTX) use in the patients studied (P<0.05)

Dr Reem Hamdy A. Mohammed (12/18/2012) comments:

It is really great and we as authors are proud of having our article selected in this great scientific citation, Mdlinx team have been also active, nonreluctant and enthausiastic in encouraging spread of scientific knowledge and anchorage of research knowledge allover

More articles in rheumatology at

Bisphosphates decrease risk of stroke

In a study involving 2148 patients on bisphosphonate therapy and 6444 matched patients with osteoporotic fractures who were followed for 2 years, the risk of stroke was significantly reduced in the former group (8.6% vs. 10.8% [HR=.79]).  Bisphosphonate users had a 0.53- and 0.81-fold risk of subarachnoid and ischemic strokes, respectively, compared to non-users.
All Posts

Trending Medical Articles

Tuesday, Apr 8, 2014
Journal of Medical Imaging and Radiation Oncology, 04/08/2014 Graham PH – The purpose of this study was to evaluate the cardiac dosimetry delivered before and after routine 3D CT whole–breast radiotherapy planning, including cardiac contouring and the relevance of a 15–mm maximum myocardial depth (MMD) planning tolerance threshold. Changes in cardiac dosimetry associated with...Read More
Monday, Mar 31, 2014
Nordic Journal of Psychiatry, 03/31/2014 Soderstrom S, et al. – The study aims to develop a Swedish Comprehensive International Classification of Functioning, Disability and Health (ICF) Core Set for adult patients with Attention–deficit hyperactivity disorder (ADHD). The Comprehensive Core Set for ADHD should be regarded as national and preliminary, and should be further tested...Read More
Wednesday, Apr 9, 2014
Pediatric Cardiology, 04/09/2014 Bockeria LA, et al. – Cardiopulmonary bypass (CPB) reduces coagulation factor levels through hemodilution and consumption. Differences in CPB–induced alterations of factor XIII (FXIII) levels in children with cyanotic and acyanotic congenital heart defects (CHDs) are not well characterized. The rational strategy of postoperative FXIII replacement...Read More
Wednesday, Mar 26, 2014
Journal of Clinical Pharmacy and Therapeutics, 03/26/2014 Zhu LQ, et al. – Drug–induced hepatotoxicity is potentially lethal. Liver transplant patients receive a large number of medications and adverse drug reactions, and drug–drug interactions must be closely monitored. Close monitoring and prompt discontinuation of the drugs with high volume of distribution and metabolized...Read More
Monday, Apr 7, 2014
International Journal of Surgical Pathology, 04/07/2014 Patriarca C, et al. – Twelve cases of urothelial cell papillary carcinoma with a whorled pattern of growth are described. All cases showed this peculiar and distinctive curlicue histological pattern, ranging from 50% to 100% of the neoplastic population. Despite the disordered/turbulent growth pattern, the cytological grade was...Read More